@FiercePharma: Shanghai Haohai Biological plans Hong Kong IPO to raise $263M. FiercePharmaAsia story | Follow @FiercePharma
@EricPFierce: ICYMI: 275 GSK jobs at risk with consumer health move from Pittsburgh. Some will get offers in New Jersey. Article | Follow @EricPFierce
@CarlyHFierce: ICYMI: Bad news, Teva--Sandoz has an FDA nod for generic Copaxone. But when will it launch? Story | Follow @CarlyHFierce
> Korea's national health insurance will cover Pfizer ($PFE) cancer drug Xalkori. More
> Massachusetts' highest court has upheld a $63 million verdict against Johnson & Johnson ($JNJ) over claims the company failed to properly warn consumers about the dangers of Children's Motrin. More
> Actavis' ($ACT) Botox has won FDA approval for the treatment of upper limb spasticity in adults. Release
> Pfizer is joining New York Gov. Andrew Cuomo's visit to Cuba. Report
> Merck ($MRK) CEO Ken Frazier has been elected chairman of the Board of the Pharmaceutical Research and Manufacturers of America (PhRMA). More
> India's Glenmark Pharmaceuticals is raising $151 million through a preferential allotment to Singapore government-owned investment firm Temasek. Report
Medical Device News
@FierceMedDev: ICYMI: NEA-backed Cartiva raises $6M after a recent FDA nod, as it heads into a PMA review. Story | Follow @FierceMedDev
@VarunSaxena2: UPDATED: HeartWare device meets trial endpoint, but stroke data a big concern. ICYMI | Follow @VarunSaxena2
@EmilyWFierce: VisualDx sees big future for mobile diagnostic tool. FierceDiagnostics report | Follow @EmilyWFierce
> FDA approves first near vision correcting implant that doesn't require cataract surgery. More
> Endo settles more than 350 vaginal mesh suits. Article
> Report: Patterson Companies looking to shed rehab supply business. Story
Biotech News
@FierceBiotech: Roche bets $555M on an Indian biotech's immuno-oncology drug. News | Follow @FierceBiotech
@JohnCFierce: What's driving the massive social media campaign for Genervon's ALS drug? (Exaggerated claims and a false assumption). Editor's corner | Follow @JohnCFierce
> Biotech guru Neil Woodford lands $1.2B for new tech fund. Report
> Data in hand, Merck shoots for Keytruda approval for lung cancer. Item
> Ampio routed as lead osteoarthritis drug flunks a PhIII test. News
> Novartis' new CAR-T hopeful looks safe in an early solid tumor study. Article
Animal Health News
> Fears of dog flu epidemic spread as questions arise about vaccine's effectiveness. News
> UN restrictions on narcotic ketamine would impede veterinary practices, trade group argues. More
> FDA coordinates with pharma to address IV fluid shortage. Item
> Cannabis biscuits sell out as lobbyists push medical marijuana rights for pets. Story
> Nexvet regroups as key study on lead dog drug shows 'low probability' of success. Article
Biotech IT News
> Sanofi sues drug information startup over side effect info. Item
> Biopharma puts better use of existing data at top of R&D wish list. More
> Apple, IBM team up for Watson-fueled assault on health research. Article
> California starts statewide precision medicine initiative with Atul Butte at the helm. Story
> PatientsLikeMe adds AstraZeneca to growing list of big-name clients. Report
And Finally... Having both depression and Type 2 diabetes may increase patients' risk of developing dementia, new research shows. More